DCs traffic between the tumor and lymph node, phagocytosing tumor cell debris and presenting peptide antigens, which are displayed on MHC-I (major histocompatibility complex class I) and MHC-II molecules, to T cell receptors (TCRs) on naïve CD8+ and CD4+ T cells, respectively. The gene discussed is CD4; the disease is neoplasm.